MARKMD

IAPP on novel genetic and phenotypic markers of Parkinson's disease and Essential Tremor

 Coordinatore EBERHARD KARLS UNIVERSITAET TUEBINGEN 

 Organization address address: GESCHWISTER-SCHOLL-PLATZ
city: TUEBINGEN
postcode: 72074

contact info
Titolo: Dr.
Nome: Holm
Cognome: Graessner
Email: send email
Telefono: -2979307
Fax: -302250

 Nazionalità Coordinatore Germany [DE]
 Totale costo 1˙173˙548 €
 EC contributo 1˙173˙548 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-IAPP-2008
 Funding Scheme MC-IAPP
 Anno di inizio 2009
 Periodo (anno-mese-giorno) 2009-03-01   -   2013-02-28

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    EBERHARD KARLS UNIVERSITAET TUEBINGEN

 Organization address address: GESCHWISTER-SCHOLL-PLATZ
city: TUEBINGEN
postcode: 72074

contact info
Titolo: Dr.
Nome: Holm
Cognome: Graessner
Email: send email
Telefono: -2979307
Fax: -302250

DE (TUEBINGEN) coordinator 595˙688.00
2    ISLENSK ERFDAGREINING EHF

 Organization address address: Sturlugata 8
city: REYKJAVIK
postcode: 101

contact info
Titolo: Mr.
Nome: Björgvin
Cognome: Richardsson
Email: send email
Telefono: -2037
Fax: -2197

IS (REYKJAVIK) participant 577˙860.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

bingen    cnv    members    decode    uuml    neuroimaging       genetics    et    clinical    disease    recruited    transfer    expertise    markers    university    genetic    pd   

 Obiettivo del progetto (Objective)

'Copy number variations (CNV) are ubiquitously found throughout in the human genome. Their role in monogenic as well as multifactorial disorders as potential disease modifier is more and more stressed (Abecasis et al., 2007). In order to investigate the role of CNV in Parkinson’s disease (PD) and Essential Tremor (ET), two frequent neurological diseases, MARKMD brings together the unique expertises of deCODE genetics (Iceland) and University of Tübingen (Germany). On the one hand, deCODE genetics will contribute and transfer its unique genetic, epidemiologic and biostatistical expertise. The University of Tübingen, on the other hand, will contribute and transfer neuroimaging and clinical expertise in regard to PD and ET. Co-operation and transfer of knowledge is dedicated to the establishment of new tools for the detection of disease associated CNV and clinical markers in patients as well as healthy at-risk groups. Thus, we anticipate to come up with new neuroimaging/clinical and genetic markers relevant to the etiology and progression of PD and ET. Transfer of knowledge will be implemented through secondments, recruitments, and meetings. There will be a structured exchange of principle investigators from both partners at project milestones facilitating the training of newly recruited team members. All recruited project members will have workpackages at either partner which allows to disseminate project outcomes easily.'

Altri progetti dello stesso programma (FP7-PEOPLE)

EPCREPAIR (2010)

Evaluation of Beneficial Role of Protein Phosphatases and KLF2 in Diabetic Endothelial and Progenitor Cell Repair

Read More  

VICQUAT (2013)

Methodology for and Synthesis of Highly Congested Molecules

Read More  

CILMITOPATHO (2013)

Investigating the role of cilia proteins in dividing cells: implications in kidney cyst formation and ciliopathies

Read More